|
2025
|
G/S
|
Pharmaceutical preparations for the treatment of mitochondrial diseases, namely, primary and seco... |
|
2024
|
Invention
|
Treatment of mitochondrial diseases.
The current invention concerns an innovative treatment for ... |
|
2022
|
Invention
|
Compounds for use in treating depression and migraine. The invention relates to amide-derivatives... |
|
|
Invention
|
Treatment of mitochondrial diseases. The current invention concerns an innovative treatment for m... |
|
2020
|
Invention
|
Compounds for treating mitochondrial disease. The invention relates to novel compounds that are u... |
|
2019
|
G/S
|
Pharmaceutical preparations for the treatment of mitochondrial diseases; pharmaceutical preparati... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of
mitochondrial diseases; pharmaceutical preparat... |
|
2018
|
G/S
|
pharmaceutical preparations for the treatment of mitochondrial diseases; pharmaceutical preparati... |
|
|
Invention
|
Compounds as mpges-1 inhibitors. The invention relates to amide-derivatives of 2-hydroxy-2-methyl... |
|
|
Invention
|
Novel compounds for use in treating depression and migraine. The invention relates to amide-deriv... |
|
2017
|
Invention
|
Novel treatment of mitochondrial diseases. The current invention concerns an innovative treatment... |
|
2016
|
Invention
|
Novel compounds for treating mitochondrial disease. The invention relates to novel compounds that... |
|
2015
|
G/S
|
Pharmaceutical and medicinal preparations and substances;
adhesive patches for medical purposes;... |
|
|
G/S
|
[ Pharmaceutical and medicinal preparations and substances for the treatment of mitochondrial dis... |
|
2013
|
Invention
|
Chromanyl derivatives for treating mitochondrial disease. The invention relates to novel compound... |
